This study evaluated the influence of receptor/G-protein (R:G) stoichiometry on constitutive activity and the efficacy of agonists, partial agonists, and inverse agonists at human (h) 5-hydroxytryphamine 1B (5-HT 1B ) receptors. Two Chinese hamster ovary cell lines were used; they expressed 8.5 versus 0.4 pmol h5-HT 1B receptors/mg (determined by [ 3 H]GR125,743 saturation analysis) and 3.0 versus 1.5 pmol receptor-activated G-
]GTP␥S binding were higher in RGhigh than in RGlow membranes. Constitutive activity (determined by inhibition of basal [ 35 S]GTP␥S binding with GTP␥S in the absence of receptor ligands) was more pronounced in RGhigh versus RGlow membranes, as revealed by the Ͼ5-fold greater proportion of HA sites. Correspondingly, the negative efficacy of inverse agonists was strikingly augmented, inasmuch as they suppressed approximately two-thirds of HA [ 35 S]GTP␥S binding in RGhigh membranes, but only approximately one-third in RGlow membranes. Furthermore, the efficacy of partial agonists was greater at RGhigh versus RGlow membranes, as estimated by their ability to enhance [ 35 S]GTP␥S binding. In conclusion, an increase in R:G ratios at h5-HT 1B receptors was associated with an increase in relative efficacy of partial agonists and, most notably, an increase in both constitutive G-protein activation and negative efficacy of inverse agonists.
In addition to characterization of the pharmacological profiles of cloned, G-protein-coupled receptors, studies of recombinant cell lines have enabled the exploration of cellular parameters that influence diverse signal transduction pathways. For example, in NIH-3T3 fibroblasts, agonist efficacies increased with augmentation of h5-HT 1A receptor expression levels (Varrault et al., 1992) , a finding corroborated by studies in other cell lines (Newman-Tancredi et al., 1997; Schoeffter et al., 1997) . Conversely, irreversible receptor inactivation by the alkylating agent, N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, reduced agonist efficacies at heterologously expressed h5-HT 1B , h5-HT 1D , and hD 3 receptors (Adham et al., 1993; Zgombick et al., 1996; NewmanTancredi et al., 1999b) . Other factors are also important in determining agonist efficacies at G-protein-coupled receptors. Thus, Fargin et al. (1989) reported that the extent of the 5-HT-induced decrease in forskolin-stimulated cAMP levels in four HeLa cell lines did not correlate with h5-HT 1A receptor expression levels, suggesting that signal transduction characteristics other than receptor density are of importance. Indeed, the efficacy of partial agonists at -opioid receptors expressed in Chinese hamster ovary (CHO) cells is related to the stoichiometric ratio of receptors to G-proteins . In a similar vein, altering receptor/G-protein (R:G) stoichiometry by G-protein coexpression increased the efficacies of agonists at muscarinic receptors (Burnstein et al., 1995) and constitutive activation of alpha-2A adrenoceptors (Pauwels et al., 2000) . Moreover, the dopamine D 4 receptor ligand, L745,870, originally characterized as an antagonist (Patel et al., 1997) , was later reported to be an agonist in different cellular expression systems, an observation attributed to differences in R:G stoichiometry (Gazi et al., 1999; P. Schoeffter, personal communication) .
The above considerations show that quantification of both receptor and G-protein expression levels is important for the appropriate interpretation of drug influences on signal transduction mechanisms (Kenakin, 1997b) . However, previous studies have focused on the influence of R:G coupling on agonist effects, whereas the influence of R:G stoichiometry on negative efficacy is relatively uncharacterized. Indeed, to our knowledge, only one study (at 5-HT 1A receptors), has investigated the influence of R:G ratios on the efficacy of inverse agonists at serotonergic receptors (Newman-Tancredi et al., 1997) .
To address these issues, we studied G-protein activation at h5-HT 1B receptors stably expressed in CHO cells.
1 5-HT 1B receptors exhibit marked constitutive activity for G-protein activation, and several inverse agonists have been identified at this site (Thomas et al., 1995; Pauwels et al., 1997; Gaster et al., 1998; Selkirk et al., 1998) . Furthermore, inhibitory 5-HT 1B receptors are located as autoreceptors on serotonergic neuronal terminals and are key targets for the modulation of serotonin release, both in the central nervous system (Engel et al., 1986; Bruinvels et al., 1993; Millan et al., 1999; Sari et al., 1999) and in the dura matter. Consequently, an understanding of the mechanisms of signal transduction by 5-HT 1B receptors is relevant to the treatment of affective disorders and to the management of migraine (Hamel, 1996; Millan, 1999) .
Herein, using two cell membrane preparations, we characterized the effects of a variation in h5-HT 1B R:G stoichiometry on several parameters. First, receptor expression levels and receptor-activated G-proteins were quantified by saturation-binding experiments, permitting the calculation of R:G ratios. Second, the competition-binding affinities of chemically diverse 5-HT 1B receptor ligands, including several recently described selective compounds, were compared in these cell membranes displaying high versus low R:G ratios. Third, ligand potencies and efficacies were compared by binding of the hydrolysis-resistant GTP analog radioligand, (Lorenzen et al., 1993) . This technique affords a measure of the activation of the first step of the intracellular transduction cascade (Birnbaumer and Birnbaumer, 1995; Gudermann et al., 1997) . Fourth, the effect of contrasting R:G ratios on constitutive 5-HT 1B receptor-mediated G-protein activation was investigated with a novel procedure using [ 35 S]GTP␥S versus GTP␥S homologous inhibition curves. Such binding isotherms allow the detection of high affinity (HA) and low affinity (LA) binding components (Breivogel et al., 1998; Selley et al., 1998) , and can be used to directly quantify the amount of agonist-independent constitutive Gprotein activation without requiring the use of inverse agonists (Audinot et al., , 2001 ). . Thus, the present isotopic dilution methodology provided a measure of the G-proteins labeled not only under the influence of agonist (10 M 5-HT), as in our previous study (Newman-Tancredi et al., 1997) but also in its absence, yielding estimates of the number and affinity of G-proteins endogenously activated in CHO-h5-HT 1B cell membranes.
Materials and Methods
Membranes and Compounds. CHO-h5-HT 1B cell membranes expressing both high and low levels of h5-HT 1B receptors were purchased from Euroscreen (Brussels, Belgium; Euroscreen only now commercializes the membranes from cells expressing the higher level of h5-HT 1B receptors). 5-HT creatinine sulfate was purchased from Sigma (Saint Quentin Fallavier, France), methiothepin maleate was from Tocris Cookson (Southampton, England). Sumatriptan (GR43,175) was from Glaxo (Greenford, UK). SB224,289 (1Ј-methyl- Table 1 and Fig. 1 ).
The number of activated G-proteins was calculated from the HA binding sites detected in biphasic [
35 S]GTP␥S versus GTP␥S isotopic dilution "saturation"-binding isotherms. This analysis takes account of those G-proteins that are constitutively activated in CHO-h5-HT 1B cells and not just those that are activated by the presence of 5-HT. In RGlow cell membranes, G-protein B max values were about 1.5 pmol/mg, both in the presence and in the absence of 5-HT (10 M). In contrast, the apparent K D value was reduced by 3-fold in the presence of 5-HT (Table 1 and Fig. 1 ). In RGhigh cell membranes, the B max values were similarly insensitive to the presence of 5-HT (10 M) (B max ϭ 2.8-3.0 pmol/mg). In contrast, 5-HT decreased the apparent K D value by 4-fold (Table 1 and Fig. 1 (Table 2 ). Marked differences in the affinities (pK i/H/L values) of certain ligands were observed between the two sets of membranes. 5-HT displayed biphasic isotherms with modest pseudo-Hill coefficients (n H ϭ 0.73) in both RGlow and RGhigh membranes, but the proportion of HA sites was significantly reduced in the latter. Sumatriptan yielded monophasic isotherms in RGlow membranes but biphasic ones in RGhigh membranes, with a significant reduction in n H value. For BMS181,101 and L775,606, pK i values were about 0.5 unit higher at RGlow than at RGhigh cell membranes. In contrast, SB224,289 exhibited a pK i value that was higher at RGhigh membranes. The other inverse agonist, methiothepin, showed a similar tendency, although it did not reach statistical significance (Table 2) . Table 4 , "Total" column). 5-HTstimulated [
Concentration-Response Effect of 5-HT
35 S]GTP␥S binding was 2937 fmol/mg/nM in RGhigh membranes (2.4-fold increase) compared with 650 fmol/mg/nM in RGlow membranes (1.4-fold increase) ( Table  4 ; "Total" column).
As concerns other 5-HT 1B receptor ligands, the following points should be noted. First, the full agonists (5-HT and sumatriptan) exhibited similar potency in both sets of membranes. Second, the partial agonists (BMS181,101 and, L775,606) exhibited increased efficacy (relative to 5-HT) in RGhigh cell membranes, with E max (maximal efficacy) values 1.3-to 1.4-fold greater than RGlow cell membranes. Third, the inverse agonists, SB224,289 and methiothepin, which exhibited only slight negative efficacy in RGlow membranes, displayed markedly (3-fold) greater negative efficacy in RGhigh cell membranes (Table 3 and Fig. 2) . ]GTP␥S binding to both RGhigh and RGlow membranes by GTP␥S produced biphasic isotherms (two-site fit was statistically superior to a single-site fit; P Ͻ .05, F test; Table 4 and Fig. 3 ). The amount of HA [
Inhibition by GTP␥S of [ 35 S]GTP␥S Binding to
35 S]GTP␥S binding (a measure of constitutive activation) was greater in RGhigh cell membranes (683 fmol/mg/nM) than in RGlow cell membranes (126 fmol/mg/nM). Furthermore, a marked difference was observed in the action of 5-HT (10 M) on HA sites in the two membrane preparations: 5-HT increased the number of HA sites by 3.7-fold in RGhigh membranes but by only 2.8-fold in RGlow membranes (Table 4 and Fig. 3) . Conversely, the number of HA sites was reduced by the inverse agonists, SB224,289 (10 M) and methiothepin (1 M), but their actions were more profound in RGhigh than in RGlow membranes (Table 4 and Fig. 3) . Indeed, methiothepin reduced 
5-HT 1B Receptor Constitutive Activity Discussion
The key findings of the present study are that an augmentation of h5-HT 1B R:G stoichiometry is associated with changes in ligand-binding affinities, increased relative efficacies of partial agonists, and, notably, increased constitutive G-protein activation and negative efficacy of inverse agonists at h5-HT 1B receptors.
Determination of R:G Stoichiometry. In a comparison of two recombinant CHO cell lines, the first (RGlow) had a low h5-HT 1B receptor expression level, whereas the second (RGhigh) expressed 20-fold more receptors (Table 1 and Fig.  1 ). Interestingly, in [ 35 S]GTP␥S saturation-binding experiments, RGhigh membranes exhibited a G-protein B max 2-fold higher than RGlow, resulting in an R:G ratio of ϳ3.0 (for RGhigh) versus ϳ0.3 (for RGlow). The present data therefore indicate that, in studies of receptor density on signal transduction, it is advisable to quantify variations in G-protein levels from one recombinant cell line to another. The R:G ratio determination methodology was similar to that used at some other receptors (Lorenzen et al., 1993; Newman-Tancredi et al., 1997; Breivogel et al., 1998; Pauwels et al., 1998 Pauwels et al., , 2000 Selley et al., 1998) . However, a distinctive aspect herein was that the density of receptor-activated G-proteins took into account those G-proteins that are endogenously activated, by calculating the amount of HA [
S]GTP␥S binding (see under Materials and Methods).
In systems that exhibit a marked degree of constitutive G-protein activation, this factor may considerably affect estimates of G-protein density and affinity (Audinot et al., , 2001 Pauwels et al., 2000) . Herein, the B max of [ 35 S]GTP␥S was not altered by the presence or absence of 5-HT (Table 1) . Thus, instead of a change in B max , 5-HT induced an increase in the apparent binding affinity of [
35 S]GTP␥S. These data are consistent with the model of agonist action proposed by Breivogel et al. (1998) , in which agonists alter G-protein affinity for guanine nucleotides (see also Gonzá lez-Maeso et al., 2000) . Thus, in CHO-h5-HT 1B cell membranes, the total number of activated G-proteins was unchanged, and the effect of the agonist, 5-HT, is to increase their ability to bind low concentrations of [ (Table 2) while maintaining a pharmacological profile in general accordance with previous reports (Plosker and McTavish, 1994; Doménech et al., 1997; Pauwels et al., 1998; Selkirk et al., 1998; Longmore et al., 2000) . It is noteworthy that the proportion of HA sites detected in RGhigh membranes for 5-HT was significantly lower than in RGlow membranes. Furthermore, the binding isotherms for sumatriptan were biphasic in RGhigh membranes but monophasic in RGlow membranes (Table 2) , and the pK i value of the partial agonist, BMS181,101, was significantly reduced in RGhigh membranes. The simplest interpretation of these observations, in the light of the increased R:G stoichiometry of RGhigh membranes, is that the proportion of G-protein-uncoupled receptors is higher. Indeed, agonists display reduced affinity at receptors that are not coupled to G-proteins (Wregget and De Léan, 1984; Kenakin, 1997a) . Conversely, the affinity (pK i values) of the inverse agonist, SB224,289, showed an increase in RGhigh membranes. Methiothepin showed a similar tendency ( Table 2 ). Given that inverse agonists exhibit higher binding affinity at receptors that exist in inactive conformation(s) (Samama et al., 1994; Leff, 1995) , this is also in accordance with the interpretation that attributes this change to an increase in the proportion of G-protein-uncoupled receptors.
Ligand Efficacy at RGhigh and RGlow Membranes. RGhigh and RGlow membranes also differed in their functional responses, as determined by [ Table 3 and Fig. 2) . First, the overall degree of stimulation attained above basal binding with 5-HT was markedly higher in RGhigh membranes (2.4-fold) than in RGlow membranes (1.4-fold) (see Table 4 ; "Total" column), probably reflecting a faster rate of G-protein "cycling" due to the greater availability of h5-HT 1B receptors per G-protein (Birnbaumer and Birnbaumer, 1995; Gudermann et al., 1997; Breivogel et al., 1998) . Thus, the relative efficacies of the partial agonists, BMS181,101 and L775,606, were also increased in RGhigh membranes versus RGlow membranes. It is important to note that the present data differ from those for 5-HT 1A receptors expressed in CHO cells (Newman-Tancredi et al., 1997) . Therein, the potency of 5-HT, but not its efficacy, was increased by an augmentation of R:G stoichiometry, whereas the reverse was true in the present study. One factor potentially implicated is that the R:G ratio of RGlow membranes herein (ϳ0.3) was substantially less than its counterpart in CHO-h5-HT 1A cell membranes (1.4; Newman-Tancredi et al., 1997). Thus, CHO-h5-HT 1B RGlow membranes may not have attained a "ceiling" whereby, for example, the number of available G-proteins was limiting, as may have been the case for CHO-h5-HT 1A RGlow cell membranes (Newman-Tancredi et al. Selley et al., 1998) . In comparison, when Gq proteins were coexpressed with m 3 receptors, both potency and efficacy were augmented (Burnstein et al., 1995) , suggesting that either or both of these parameters may be affected, depending on the R:G stoichiometry and limiting factors in each cellular expression system. These data again highlight the importance of thoroughly characterizing different expression systems at the level of both receptor and coupled G-proteins. Second, inverse agonists displayed increased negative efficacy in RGhigh membranes. Indeed, in RGlow membranes, the inhibitory actions of methiothepin were modest, whereas in RGhigh membranes about 40% of basal [ 35 S]GTP␥S binding was inhibited by SB224,289 and methiothepin (Table 3 and Fig. 2 ). These data are reminiscent of observations at CHO-h5-HT 1A cell membranes showing that an increase in R:G ratio augmented the negative efficacy of the inverse agonist, spiperone (Newman-Tancredi et al., 1997) . The most likely explanation is that inverse agonists stabilize G-protein-coupled (as well as uncoupled) receptors in inactive conformation(s) (Samama et al., 1994; Leff, 1995; Newman-Tancredi et al., 1997) . This would result in a reduction in the pool of G-proteins available for activation by non-inverse agonist-occupied receptors. The present data therefore provide evidence that R:G stoichiometry is an important factor in the detection of inverse agonist actions at h5-HT 1B receptor-coupled G-proteins.
S]GTP␥S binding (
Constitutive Activity at RGhigh and RGlow Membranes. The degree of constitutive h5-HT 1B receptor activation differed markedly between RGhigh and RGlow membranes. As stated in the introduction, the quantitative influence of R:G stoichiometry on constitutive activity is poorly characterized. Herein, constitutive activity was directly quantified by an innovative procedure by which the HA and LA components of homologous inhibition experiments of [ 35 S]GTP␥S versus GTP␥S (Audinot et al., , 2000 were analyzed. The stimulatory action of 5-HT on [ 35 S]GTP␥S binding was due to an action on HA sites, consistent with results at other receptor systems (Breivogel et al., 1998; Pauwels et al., 1998 Pauwels et al., , 2000 Selley et al., 1998) , but the key finding of the present study was the increase in the number of HA sites observed in RGhigh cell membranes under basal conditions. Indeed, HA binding in RGhigh membranes was 5-fold greater (683 fmol/mg/nM; Table 4 and Fig. 3 ) than that observed in RGlow membranes (126 fmol/mg/nM). Given that in both cases no agonists were present, the increase is, most likely, attributable to increased R:G stoichiometry (Kenakin, 1997a) . Thus, as R:G stoichiometry increases, the augmented availability of receptors per G-protein favors coupling of the latter to receptors in active conformations, yielding a greater amount of HA binding in the absence of agonist (i.e., constitutive activity). In contrast, LA binding increases by only about 2-fold in RGhigh membranes relative to RGlow membranes, a change similar to the increase in the B max derived from [
35 S]GTP␥S saturation binding (Table 1) . Indeed, receptor ligands (whether agonists or inverse agonists) have little, if any, influence on LA sites but exert a major influence on HA binding. Indeed, the present study reveals that methiothepin and SB224,289 reduced the number of HA sites, an effect that was more pronounced in RGhigh membranes than in RGlow membranes. These observations suggest that as R:G stoichiometry increases, the number of constitutively active receptors per G-protein increases, thus providing a greater basal activity on which inverse agonists can exert their inhibitory actions. These data are consistent with a two-state receptor activation model (Leff, 1995; Kenakin, 1997a) but, once again, differ from those obtained for CHOh5-HT 1A receptors (Newman-Tancredi et al., 1997) . For the latter, basal [
35 S]GTP␥S binding was not altered by the increase in R:G ratio, whereas for h5-HT 1B receptors it was (Table 4) . As discussed above, these data suggest that h5- 35 S]GTP␥S binding in the present CHO cell line is not subject to the same limitation or ceiling as h5-HT 1A receptors in our previous study (Newman-Tancredi et al., 1997; Selley et al., 1998) . The limiting factor could be the G-protein expression level, which was ϳ1 pmol/mg for CHO-h5-HT 1A membranes but ϳ3 pmol/mg for RGhigh membranes in the present study.
Conclusions
The present study provides evidence that R:G stoichiometry is a key factor in the pharmacological profile of h5-HT 1B receptors in CHO cells. Increased R:G ratios are associated with alterations in binding affinity, increased G-protein activation by full agonists, and increased relative efficacy of partial agonists at h5-HT 1B receptors. Importantly, the present study reveals that increased R:G ratios are also associated with increased negative efficacy of inverse agonists and increased constitutive G-protein activation of h5-HT 1B receptors, effects that may be receptor subtype dependent, because they differ from previously reported data at h5-HT 1A receptors. The implications of the present observations for analysis of data obtained from native 5-HT 1B , or other G-protein-coupled receptors, remains to be more fully ascertained but suggest that determination of R:G stoichiometry is an important parameter to consider when interpreting data pertaining to ligand efficacy and receptor constitutive activity.
